The fight against COVID-19 seemed to turn a corner when the Pfizer and Moderna vaccines came out. But researchers are now finding that one vulnerable group of people could remain at risk. That's because the vaccines may not produce enough of an antibody response. Ash-har Quraishi has more on the group some scientists are concerned about.